Ding XW - Search Results

1

Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women.

Cao WM, Zheng YB, Gao Y, Ding XW, Sun Y, Huang Y, Lou CJ, Pan ZW, Peng G, Wang XJ. Cao WM, et al. Among authors: ding xw. BMC Cancer. 2019 Jun 7;19(1):551. doi: 10.1186/s12885-019-5765-3. BMC Cancer. 2019. PMID: 31174498 Free PMC article.

2

Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancer.

Cao WM, Gao Y, Yang HJ, Xie SN, Ding XW, Pan ZW, Ye WW, Wang XJ. Cao WM, et al. Among authors: ding xw. BMC Cancer. 2016 Feb 6;16:64. doi: 10.1186/s12885-016-2107-6. BMC Cancer. 2016. PMID: 26852015 Free PMC article.

3

Deleterious Mutations in DNA Repair Gene FANCC Exist in BRCA1/2-Negative Chinese Familial Breast and/or Ovarian Cancer Patients.

Pan ZW, Wang XJ, Chen T, Ding XW, Jiang X, Gao Y, Mo WJ, Huang Y, Lou CJ, Cao WM. Pan ZW, et al. Among authors: ding xw. Front Oncol. 2019 Mar 22;9:169. doi: 10.3389/fonc.2019.00169. eCollection 2019. Front Oncol. 2019. PMID: 30967997 Free PMC article.

4

Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.

Mo W, Ding Y, Zhao S, Zou D, Ding X. Mo W, et al. PLoS One. 2020 Nov 10;15(11):e0241924. doi: 10.1371/journal.pone.0241924. eCollection 2020. PLoS One. 2020. PMID: 33170908 Free PMC article.

5

A comprehensive analysis of Fanconi anemia genes in Chinese patients with high-risk hereditary breast cancer.

Zhu QY, Li PC, Zhu YF, Pan JN, Wang R, Li XL, Ye WW, Ding XW, Wang XJ, Cao WM. Zhu QY, et al. Among authors: ding xw. J Cancer Res Clin Oncol. 2023 Nov;149(15):14303-14313. doi: 10.1007/s00432-023-05236-6. Epub 2023 Aug 11. J Cancer Res Clin Oncol. 2023. PMID: 37566130 Free PMC article.

6

HR-positive/HER2-negative breast cancer arising in patients with or without BRCA2 mutation: different biological phenotype and similar prognosis.

Li PC, Zhu YF, Pan JN, Zhu QY, Liao YY, Ding XW, Zheng LF, Cao WM. Li PC, et al. Among authors: ding xw. Ther Adv Med Oncol. 2024 Apr 10;16:17588359241242613. doi: 10.1177/17588359241242613. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38606163 Free PMC article.

7

AcornHRD: an HRD algorithm highly associated with anthracycline-based neoadjuvant chemotherapy in breast cancer in China.

Pan JN, Li PC, Wang M, Li MW, Ding XW, Zhou T, Wang HN, Wang YK, Chen LB, Wang R, Ye WW, Wu WZ, Lou F, Wang XJ, Cao WM. Pan JN, et al. Among authors: ding xw. Eur J Med Res. 2024 Jul 16;29(1):366. doi: 10.1186/s40001-024-01936-y. Eur J Med Res. 2024. PMID: 39014466 Free PMC article.

8

Associations between folate metabolism enzyme polymorphisms and breast cancer: A meta-analysis.

Mo W, Ding Y, Zheng Y, Zou D, Ding X. Mo W, et al. Breast J. 2020 Mar;26(3):484-487. doi: 10.1111/tbj.13527. Epub 2019 Sep 23. Breast J. 2020. PMID: 31549463

9

The treatment option of progressive disease in breast cancer during neoadjuvant chemotherapy: a single-center experience.

Zheng Y, Ding X, Zou D, Zhang F, Qin C, Yang H, Mo W, Ding Y, Yu Y. Zheng Y, et al. Cancer Biol Ther. 2020 Aug 2;21(8):675-687. doi: 10.1080/15384047.2020.1756707. Epub 2020 May 18. Cancer Biol Ther. 2020. PMID: 32420815 Free PMC article.

10

Primary study of lymph node metastasis-related serum biomarkers in breast cancer.

Wang L, Su D, Yan HJ, Xu JH, Zheng ZG, Hu YJ, Pan XD, Ding XW, Chen C, Chen B, Mao WM, Meng XL. Wang L, et al. Among authors: ding xw. Anat Rec (Hoboken). 2011 Nov;294(11):1818-24. doi: 10.1002/ar.21455. Epub 2011 Oct 1. Anat Rec (Hoboken). 2011. PMID: 21964916 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters